~~<i id='CFDAC40BB4'><strike id='CFDAC40BB4'><tt id='CFDAC40BB4'><pre id='CFDAC40BB4'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

leisure time

author：leisure time 2025-10-01 02:13:21 - browse：7

MADRID — Merck is paying billions of dollars to partner with Daiichi Sankyo on a series of cancer drugs, underscoring the excitement around targeted chemotherapy treatments.

The deal includes a $4 billion upfront payment and an additional $1.5 billion over the next two years. Up to $16.5 billion more is on the table depending on the success of the drugs in development.

The announcement on Thursday night in the United States came on the eve of one the cancer field’s biggest annual conferences, the European Society for Medical Oncology Congress, being held this year in Madrid.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In Memoriam: Notable people who died in 2023
Next article： US soldier in North Korean custody after crossing DMZ line

focus

hotspot

explore

leisure time

hotspot

IsraelisblockahighwayastheyprotestagainstplansbyPrimeMinisterBenjaminNetanyahu'sgovernmenttooverhaul

WSS

Why rehabilitation engineers need to center patients in their research

ER docs worry over extreme heat as a 'mass casualty event'

What we know about the American soldier detained in North Korea

Manchin plays down potential 3rd

Cholera vaccine supply gets boost as demand surges globally

Why you get paid to donate plasma but not blood

leisure time

leisure time

focus

Cancer drug shortages should be causing more outrage

Cell therapy fails to slow type 1 diabetes, but safety is established

United colonoscopy coverage change 'may cost lives,' doctors say

Health care needs a new profession: neuroimaging counseling

Psychedelics group wrestles with new pharma identity

Why you get paid to donate plasma but not blood

Moonlake's readout produced a cash windfall. Risks remain

Phoenix breaks record with 19 consecutive days above 110 degrees Fahrenheit

BioMarin wins approval for gene therapy to treat hemophilia A

Search resumes for 2 missing children washed away with mom in deadly Pennsylvania flash flood

focus

More hospitals are billing patients as online messages surge

Search resumes for 2 missing children washed away with mom in deadly Pennsylvania flash flood

MultiPlan and major insurers sued for alleged medical price

More tobacco lobbyists active in statehouses

Element Biosciences CEO lays out genome sequencing strategy

FTC falls short on scrutinizing hospital mergers, study says

hotspot

explore

leisure time

hotspot